Optimized seasonal influenza mRNA vaccine compositions demonstrate safety and enhanced immunogenicity in a phase 2 study
Seasonal influenza causes considerable morbidity and mortality, with influenza A and B viruses driving most influenza-associated hospitalizations and deaths. Vaccination remains a key influenza prevention strategy; however, current seasonal influenza vaccines based on traditional platforms provide i...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2026-12-01
|
| Seria: | Human Vaccines & Immunotherapeutics |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.tandfonline.com/doi/10.1080/21645515.2026.2694211 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
